Cite

HARVARD Citation

    Zhuo, C. et al. (2020). Adjunct ketamine treatment of depression in treatment‐resistant schizophrenia patients is unsatisfactory in pilot and secondary follow‐up studies. Brain and behavior. 10 (5), p. n/a. [Online]. 
  
Back to record